An agreement (75% agree and 19% neutral) on the beneficial effect of antibacterial envelope for both CIED infection prevention and pocket stabilization was also reached for patients with insulin‐treated diabetes, defined as being under insulin use, independently of CIED device type and of any other risk factors. The gene discussed is INS; the disease is diabetes mellitus.